Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: April 4, 2023
Abstract
Recently
it
has
been
identified
that
circRNAs
can
act
as
miRNAs
sponge
to
regulate
gene
expression
in
various
types
of
cancers
associate
with
cancer
initiation
and
progression.
The
present
study
aims
identify
colorectal
cancer-related
the
underpinning
mechanisms
circRNA/miRNA/mRNA
networks
development
progress
Colorectal
Cancer.
Differentially
expressed
circRNAs,
miRNAs,
mRNAs
were
GEO
microarray
datasets
using
Limma
package
R.
analysis
resulted
23
upregulated
31
downregulated
circRNAs.
CeRNAs
constructed
by
intersecting
results
predicted
experimentally
validated
databases,
circbank
miRWalk,
DEMs
DEGs
Cytoscape.
Then,
functional
enrichment
was
performed
for
included
ceRNA
networks.
Followed
survival
analysis,
profile
validation
TCGA
data,
ROC
curve
we
reached
a
sub-networks
which
revealed
potential
regulatory
effect
hsa_circ_0001955
hsa_circ_0071681
on
survival-related
genes,
KLF4,
MYC,
CCNA2,
RACGAP1,
CD44.
Overall,
convoluted
network
likely
its
action
CRC,
may
contribute
developing
more
effective
approaches
early
diagnosis,
prognosis,
treatment
CRC.
Cell Death and Disease,
Journal Year:
2023,
Volume and Issue:
14(6)
Published: June 9, 2023
Abstract
Globally,
colorectal
cancer
(CRC)
is
the
third
most
prevalent
and
second
leading
cause
of
cancer-related
deaths.
Circular
RNAs
(circRNAs)
are
single-stranded
RNA
with
covalently
closed-loop
structures
highly
stable,
conserved,
abundantly
expressed
in
various
organs
tissues.
Recent
research
found
abnormal
circRNA
expression
CRC
patients’
blood/serum,
cells,
tissues,
exosomes.
Furthermore,
mounting
data
demonstrated
that
circRNAs
crucial
to
development
CRC.
CircRNAs
have
been
shown
exert
biological
functions
by
acting
as
microRNA
sponges,
RNA-binding
protein
regulators
gene
splicing
transcription,
protein/peptide
translators.
These
characteristics
make
potential
markers
for
diagnosis
prognosis,
therapeutic
targets,
circRNA-based
therapies.
However,
further
studies
still
necessary
improve
understanding
roles
mechanisms
In
this
review,
up-to-date
on
role
was
examined,
focusing
their
application
targeted
therapy,
which
would
advance
knowledge
progression
Cancer Letters,
Journal Year:
2023,
Volume and Issue:
569, P. 216318 - 216318
Published: July 15, 2023
The
immunosuppressive
molecule
programmed
death-ligand
1
(PD-L1)
is
frequently
upregulated
in
human
cancers.
Binding
of
PD-L1
to
its
receptor,
death-1
(PD-1),
on
activated
T
cells
facilitates
cancer
evade
the
host
immune
system.
Antibody-based
PD-1/PD-L1
inhibitors
can
inhibit
interaction
allowing
reactivate
cytotoxic
eradicate
advanced
cells.
However,
majority
patients
fail
respond
anti-PD-1/PD-L1
therapies
and
molecular
mechanisms
for
this
remain
poorly
understood.
Recent
studies
show
that
expression
level
tumor
affect
clinical
efficacy
checkpoint
therapies.
Thus,
furthering
our
understanding
regulatory
will
be
critical
improve
response
rates
Here
we
review
recent
studies,
primarily
focusing
regulate
at
transcriptional,
post-transcriptional
protein
level,
with
purpose
drive
development
more
targeted
effective
MedComm,
Journal Year:
2024,
Volume and Issue:
5(9)
Published: Sept. 1, 2024
Abstract
Circular
RNAs
(circRNAs)
are
a
unique
class
of
RNA
molecules
formed
through
back‐splicing
rather
than
linear
splicing.
As
an
emerging
field
in
molecular
biology,
circRNAs
have
garnered
significant
attention
due
to
their
distinct
structure
and
potential
functional
implications.
A
comprehensive
understanding
circRNAs’
functions
clinical
applications
remains
elusive
despite
accumulating
evidence
involvement
disease
pathogenesis.
Recent
research
highlights
roles
various
human
diseases,
but
reviews
on
remain
scarce.
This
review
provides
in‐depth
examination
circRNAs,
focusing
first
non‐neoplastic
diseases
such
as
respiratory,
endocrine,
metabolic,
musculoskeletal,
cardiovascular,
renal
disorders.
We
then
explore
tumors,
with
particular
emphasis
exosomal
circular
RNAs,
which
crucial
for
cancer
initiation,
progression,
resistance
treatment.
By
detailing
biogenesis,
functions,
impact
mechanisms,
this
underscores
the
diagnostic
biomarkers
therapeutic
targets.
The
not
only
enhances
our
specific
tumor
types
also
novel
tools,
thereby
paving
way
future
investigations
interventions.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 9, 2024
Colorectal
cancer
(CRC)
and
inflammatory
bowel
disease
(IBD)
are
escalating
global
health
concerns.
Despite
their
distinct
clinical
presentations,
both
disorders
share
intricate
genetic
molecular
interactions.
The
Hippo
signaling
pathway
plays
a
crucial
role
in
regulating
cell
processes
is
implicated
the
pathogenesis
of
IBD
CRC.
Circular
RNAs
(circRNAs)
have
gained
attention
for
roles
various
diseases,
including
However,
comprehensive
understanding
specific
circRNAs
involved
CRC,
functional
lacking.
Here,
it
found
that
circHIPK2
(hsa_circRNA_104507)
bona
fide
circRNA
consistently
upregulated
CRC
suggesting
its
potential
as
biomarker.
Furthermore,
silencing
suppressed
growth
cells
vitro
vivo.
Interestingly,
decreased
circHipk2
potentiated
dextran
sulfate
sodium
(DSS)-induced
colitis
but
alleviated
colitis-associated
tumorigenesis.
Most
significantly,
mechanistic
investigations
further
unveil
circHIPK2,
mediated
by
FUS,
interacting
with
EIF4A3
to
promote
translation
TAZ,
ultimately
increasing
transcription
downstream
target
genes
CCN1
CCN2.
Taken
together,
emerges
key
player
shared
mechanisms
modulating
pathway.
CircHIPK2-EIF4A3
axis
contributes
intestinal
epithelial
enhancing
TAZ
translation.
Cancer Biology and Medicine,
Journal Year:
2023,
Volume and Issue:
20(2), P. 104 - 128
Published: March 2, 2023
Circular
RNAs
(circRNAs)
form
a
class
of
endogenous
single-stranded
RNA
transcripts
that
are
widely
expressed
in
eukaryotic
cells.
These
mediate
post-transcriptional
control
gene
expression
and
have
multiple
functions
biological
processes,
such
as
transcriptional
regulation
splicing.
They
serve
predominantly
microRNA
sponges,
RNA-binding
proteins,
templates
for
translation.
More
importantly,
circRNAs
involved
cancer
progression,
may
promising
biomarkers
tumor
diagnosis
therapy.
Although
traditional
experimental
methods
usually
time-consuming
laborious,
substantial
progress
has
been
made
exploring
potential
circRNA-disease
associations
by
using
computational
models,
summarized
signaling
pathway
data,
other
databases.
Here,
we
review
the
characteristics
circRNAs,
including
their
roles
cancer.
Specifically,
focus
on
pathways
associated
with
carcinogenesis,
status
circRNA-associated
bioinformatics
Finally,
explore
prognostic
Pharmacological Research,
Journal Year:
2024,
Volume and Issue:
207, P. 107345 - 107345
Published: Aug. 10, 2024
Inflammation
is
the
response
of
human
body
to
injury,
infection,
or
other
abnormal
states,
which
involved
in
development
many
diseases.
As
a
member
Krüppel-like
transcription
factors
(KLFs)
family,
KLF4
plays
crucial
regulatory
role
physiological
and
pathological
processes
due
its
unique
dual
domain
transcriptional
activation
inhibition.
A
growing
evidence
has
demonstrated
that
pivotal
pathogenesis
various
inflammatory
disorders,
including
bowel
disease,
osteoarthritis,
renal
inflammation,
pneumonia,
neuroinflammation,
so
on.
Consequently,
emerged
as
promising
new
therapeutic
target
for
This
review
systematically
generalizes
molecular
network,
specific
functions,
mechanisms
elucidate
complex
roles
An
in-depth
study
on
biological
function
anticipated
offer
novel
research
perspective
potential
intervention
strategies
Non-coding RNA Research,
Journal Year:
2025,
Volume and Issue:
12, P. 67 - 80
Published: Feb. 21, 2025
miR-135b,
a
microRNA,
is
consistently
up-regulated
in
various
cancer
tissues
and
cells,
promoting
progression.
By
inhibiting
one
or
more
target
genes,
miR-135b
regulates
phenotypes
such
as
growth,
apoptosis,
migration,
invasion,
drug
resistance,
angiogenesis,
establishing
it
critical
driver
of
Additionally,
regulated
by
oncogenes
therapeutic
drugs,
highlighting
its
complexity
potential.
Significant
progress
has
been
made
understanding
miR-135b's
impact
on
cell
behavior,
promising
biomarker
for
diagnosis
prognosis,
well
potential
future
therapies.
However,
despite
the
extensive
research
this
topic,
there
no
comprehensive
review
summarizing
role
mechanisms
across
different
types.
This
aims
to
provide
detailed
overview
biological
characteristics
regulatory
targets,
upstream
signaling
pathways,
potential,
including
influence
chemoresistance.
The
also
addresses
key
controversies
surrounding
research,
aiming
deepen
role,
promote
transformation
clinical
application,
theoretical
foundation
developing
effective
treatment
strategies.
Frontiers in Oncology,
Journal Year:
2023,
Volume and Issue:
13
Published: March 6, 2023
Colorectal
cancer
(CRC)
is
a
leading
cause
of
cancer-related
death
worldwide
due
to
the
lack
effective
diagnosis
and
prognosis
biomarkers
therapeutic
targets,
resulting
in
poor
patient
survival
rates.
Circular
RNA
(circRNA)
type
endogenous
non-coding
(ncRNA)
with
closed-loop
structure
that
plays
crucial
role
physiological
processes
pathological
diseases.
Recent
studies
indicate
circRNAs
are
involved
diagnosis,
prognosis,
drug
resistance,
development
tumors,
particularly
CRC.
Therefore,
circRNA
could
be
potential
new
target
for
improving
CRC
treatment.
This
review
focuses
on
origin
biological
functions
circRNA,
summarizes
recent
research
circRNA's
CRC,
discusses
use
as
clinical
well
targets